
Transactions
Filter


Sale of Evondos (FI) by Serendipity Partners (NO) — Amount not disclosed

Acquisition of a majority stake in Eleda Infra Services Group (SE) by Altor Fund V (SE) — Amount not disclosed

Directed new share issue in Oncopeptides AB (SE) — SEK 1.4 billion

Directed new share issue in BerGenBio´s ASA (NO) — NOK 500 million

Acquisition of Saber Interactive Inc. (US) by Embracer Group (SE) — USD 525 million

Directed share issue in NCAB Group AB (SE) — SEK 287 million

Directed new share issue in Nordic Aquafarms AS (NO) – NOK 88 million

Rights issue in Bambuser AB (SE) — SEK 101 million

Directed new share issue in Enad Global 7 AB (SE) – SEK 119 million

Directed share issue in Faron Pharmaceuticals Oy (FI) – EUR 14.0 million
